Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 13Gastrointestinal 7Thoracic 6Other hematologic neoplasm 3Myeloid 3Sarcoma 2Lymphoid 2Breast 2Plasma cell 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Neuroendocrine Tumors 130Pituitary Neoplasms 72Thyroid Cancer, Papillary 59Pheochromocytoma 54Multiple Endocrine Neoplasia Type 1 31Thyroid Neoplasms 30Paraganglioma 28Adrenal Gland Neoplasms 27Neoplasms 26Pancreatic Neoplasms 21Carcinoid Tumor 20Adrenocortical Carcinoma 19Hyperaldosteronism 17Cushing Syndrome 17Carcinoma, Neuroendocrine 17Gastro-enteropancreatic neuroendocrine tumor 16Acromegaly 15Pituitary Diseases 14Lung Neoplasms 13Stomach Neoplasms 11Prostatic Neoplasms 11Neoplasm Metastasis 11Carcinoma, Hepatocellular 11Breast Neoplasms 11Multiple Endocrine Neoplasia 10Melanoma 10Thyroid Carcinoma, Anaplastic 9Prolactinoma 9Lymphatic Metastasis 9Insulinoma 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms, Second Primary × Endocrine × Clear all
NCT07291752 2025-12-18

The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022

Suez Canal University

Completed
93,481 enrolled
Endocrine

Carcinoid Tumor, Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡